文献速递胃肠外科急腹症与外科感染

左侧结直肠癌梗阻的内镜下支架置入随机临床试验(CReST)

Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial.
PubMed 文献 · Br J Surg · 2022-01-01

CReST 试验将左侧结肠癌梗阻患者随机分配至内镜下支架置入后择期手术或急诊手术,发现两组 30 天死亡率和住院时间无显著差异,但支架组造口形成率更低。

要点

  • 支架作为手术桥梁可降低造口形成率,且不增加并发症。
  • 两组 30 天死亡率和住院时间无显著差异。
  • 支架置入技术成功率高,但需注意梗阻缓解率。

核心结论

  • 支架作为手术桥梁可减少造口形成,且无不良影响。

研究设计与样本

  • 多中心随机对照试验,纳入 39 家医院 245 例左侧结肠梗阻且影像学提示癌的患者。

主要发现

  • 支架置入尝试率 96.7%(119/123),梗阻缓解率 82.4%(98/119)。
  • 治愈性治疗患者中,支架组 30 天死亡率 3.6%(4/110) vs 急诊手术组 5.6%(6/107),P=0.48。
  • 住院时间中位数支架组 19 天(IQR 11-34) vs 急诊手术组 18 天(IQR 10-28),P=0.94。
  • 造口形成率支架组 47.5%(47/99) vs 急诊手术组 67.9%(72/106),P=0.003。

临床怎么用

  • 对于左侧结肠癌梗阻需择期手术的患者,可考虑内镜下支架置入作为桥梁以降低造口率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Colorectal cancer often presents with obstruction needing urgent, potentially life-saving decompression. The comparative efficacy and safety of endoluminal stenting versus emergency surgery as initial treatment for such patients is uncertain. METHODS: Patients with left-sided colonic obstruction and radiological features of carcinoma were randomized to endoluminal stenting using a combined endoscopic/fluoroscopic technique followed by elective surgery 1-4 weeks later, or surgical decompression with or without tumour resection. Treatment allocation was via a central randomization service using a minimization procedure stratified by curative intent, primary tumour site, and severity score (Acute Physiology And Chronic Health Evaluation). Co-primary outcome measures were duration of hospital stay and 30-day mortality. Secondary outcomes were stoma formation, stenting completion and complication rates, perioperative morbidity, 6-month survival, 3-year recurrence, resource use, adherence to chemotherapy, and quality of life. Analyses were undertaken by intention to treat. RESULTS: Between 23 April 2009 and 22 December 2014, 245 patients from 39 hospitals were randomized. Stenting was attempted in 119 of 123 allocated patients (96.7 per cent), achieving relief of obstruction in 98 of 119 (82.4 per cent). For the 89 per cent treated with curative intent, there were no significant differences in 30-day postoperative mortality (3.6 per cent (4 of 110) versus 5.6 per cent (6 of 107); P = 0.48), or duration of hospital stay (median 19 (i.q.r. 11-34) versus 18 (10-28) days; P = 0.94) between stenting followed by delayed elective surgery and emergency surgery. Among patients undergoing potentially curative treatment, stoma formation occurred less frequently in those allocated to stenting than those allocated to immediate surgery (47 of 99 (47.5 per cent) versus 72 of 106 (67.9 per cent); P = 0.003). There were no significant differences in perioperative morbidity, critical care use, quality of life, 3-year recurrence or mortality between treatment groups. CONCLUSION: Stenting as a bridge to surgery reduces stoma formation without detrimental effects. Registration number: ISRCTN13846816 (http://www.controlled-trials.com).

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial. Br J Surg. 2022. PMID: 35986684. doi:10.1093/bjs/znac141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。